See more : London Stock Exchange Group plc (LNSTY) Income Statement Analysis – Financial Results
Complete financial analysis of ImpediMed Limited (IPD.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ImpediMed Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Bank of the Philippine Islands (BPHLF) Income Statement Analysis – Financial Results
- Taewoong Co.,Ltd (044490.KQ) Income Statement Analysis – Financial Results
- PT Atlas Resources Tbk (ARII.JK) Income Statement Analysis – Financial Results
- Kalyan Capitals Limited (KALYANCAP.BO) Income Statement Analysis – Financial Results
- KnightSwan Acquisition Corporation (KNSW) Income Statement Analysis – Financial Results
ImpediMed Limited (IPD.AX)
About ImpediMed Limited
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.32M | 11.34M | 10.57M | 8.41M | 5.74M | 4.16M | 3.32M | 5.77M | 5.79M | 4.84M | 3.52M | 2.73M | 2.95M | 3.89M | 3.64M | 2.99M | 2.31M | 0.00 |
| Cost of Revenue | 1.31M | 25.00M | 23.92M | 20.61M | 18.63M | 1.25M | 976.00K | 1.49M | 1.58M | 1.32M | 968.00K | 1.17M | 1.27M | 1.66M | 1.61M | 1.43M | 693.60K | 0.00 |
| Gross Profit | 9.01M | -13.65M | -13.35M | -12.20M | -12.89M | 2.90M | 2.34M | 4.28M | 4.21M | 3.52M | 2.55M | 1.56M | 1.68M | 2.23M | 2.03M | 1.56M | 1.62M | 0.00 |
| Gross Profit Ratio | 87.27% | -120.36% | -126.35% | -145.11% | -224.49% | 69.87% | 70.58% | 74.18% | 72.66% | 72.67% | 72.51% | 57.04% | 57.05% | 57.40% | 55.78% | 52.30% | 69.99% | 0.00% |
| Research & Development | 221.00K | 598.00K | 683.00K | 1.46M | 3.31M | 3.37M | 2.96M | 5.34M | 4.04M | 1.03M | 401.00K | 554.00K | 2.78M | 1.38M | 1.27M | 2.93M | 1.83M | 0.00 |
| General & Administrative | 22.10M | 5.33M | 4.85M | 4.87M | 4.61M | 4.50M | 6.99M | 6.11M | 7.73M | 3.53M | 3.04M | 3.12M | 7.62M | 11.37M | 8.01M | 6.47M | 4.67M | 0.00 |
| Selling & Marketing | 524.00K | 458.00K | 669.00K | 447.00K | 875.00K | 714.00K | 819.00K | 1.20M | 1.30M | 1.30M | 477.00K | 454.00K | 777.00K | 499.00K | 165.00K | 646.42K | 403.08K | 0.00 |
| SG&A | 22.62M | 8.59M | 7.19M | 9.36M | 9.31M | 22.83M | 29.67M | 29.47M | 28.48M | 17.48M | 10.05M | 10.26M | 8.39M | 11.87M | 8.17M | 7.12M | 5.08M | 0.00 |
| Other Expenses | 0.00 | 1.70M | 1.69M | 2.44M | 4.19M | 2.70M | 3.06M | -560.00K | 43.00K | 265.00K | 10.00K | 791.00K | 777.00K | 84.00K | 52.00K | 62.80K | 1.12M | 0.00 |
| Operating Expenses | 28.04M | 9.19M | 7.88M | 10.82M | 12.62M | 27.22M | 29.98M | 32.17M | 30.34M | 18.40M | 10.55M | 10.22M | 15.15M | 17.49M | 13.72M | 15.73M | 11.46M | 0.00 |
| Cost & Expenses | 29.36M | 34.19M | 31.79M | 31.43M | 31.25M | 28.47M | 30.95M | 33.66M | 31.93M | 19.72M | 11.51M | 11.39M | 16.41M | 19.14M | 15.33M | 17.16M | 12.15M | 0.00 |
| Interest Income | 1.56M | 801.00K | 46.00K | 21.00K | 112.00K | 371.00K | 428.00K | 367.00K | 156.00K | 83.00K | 57.00K | 192.00K | 239.00K | 285.00K | 168.00K | 279.19K | 652.80K | 0.00 |
| Interest Expense | 93.00K | 34.00K | 28.00K | 52.00K | 73.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.00K | 1.00K | 4.47K | 1.69M | 0.00 |
| Depreciation & Amortization | 2.25M | 2.47M | 2.77M | 1.70M | 1.44M | 692.00K | 433.00K | 272.00K | 204.00K | 175.00K | 176.00K | 208.00K | 574.00K | 665.00K | 737.00K | 771.76K | 355.05K | 0.00 |
| EBITDA | -22.05M | -20.49M | -18.65M | -20.70M | -24.07M | -26.33M | -30.35M | -30.52M | -26.00M | -14.97M | -7.84M | -9.24M | -12.89M | -14.14M | -10.66M | -13.25M | -7.71M | 0.00 |
| EBITDA Ratio | -213.69% | -179.65% | -174.69% | -253.50% | -419.33% | -643.31% | -914.65% | -529.29% | -488.76% | -309.04% | -222.52% | -338.05% | -437.72% | -363.88% | -293.05% | -436.27% | -333.58% | 0.00% |
| Operating Income | -19.04M | -22.85M | -21.23M | -23.02M | -25.51M | -26.96M | -30.71M | -30.78M | -28.50M | -15.15M | -8.01M | -9.45M | -13.47M | -15.25M | -11.69M | -14.17M | -9.81M | 0.00 |
| Operating Income Ratio | -184.48% | -201.39% | -200.90% | -273.72% | -444.35% | -648.70% | -925.62% | -533.82% | -492.13% | -312.65% | -227.52% | -345.66% | -457.22% | -392.44% | -321.30% | -473.45% | -424.37% | 0.00% |
| Total Other Income/Expenses | -1.69M | -4.07M | -4.15M | -2.02M | 1.58M | 3.02M | 3.09M | 2.99M | 2.34M | 348.00K | 67.00K | 983.00K | 1.12M | 432.00K | 290.00K | 137.62K | 54.80K | 0.00 |
| Income Before Tax | -20.73M | -22.08M | -21.45M | -22.46M | -23.94M | -23.95M | -27.21M | -27.53M | -25.98M | -14.80M | -7.94M | -8.46M | -12.34M | -14.82M | -11.40M | -14.03M | -9.75M | 0.00 |
| Income Before Tax Ratio | -200.84% | -194.61% | -202.98% | -267.04% | -416.91% | -576.16% | -819.95% | -477.47% | -448.63% | -305.47% | -225.36% | -309.70% | -419.08% | -381.32% | -313.33% | -468.85% | -422.00% | 0.00% |
| Income Tax Expense | -935.00K | -1.56M | -1.57M | -1.75M | -2.56M | 51.00K | 42.00K | 40.00K | -2.35M | 0.00 | 0.00 | 0.00 | -346.00K | 97.00K | 53.00K | 67.27K | 2.81M | 0.00 |
| Net Income | -19.79M | -20.52M | -19.87M | -20.71M | -21.38M | -24.00M | -27.25M | -27.57M | -25.98M | -14.80M | -7.94M | -8.46M | -12.34M | -14.82M | -11.40M | -14.03M | -9.75M | 0.00 |
| Net Income Ratio | -191.78% | -180.90% | -188.09% | -246.24% | -372.36% | -577.38% | -821.22% | -478.17% | -448.63% | -305.47% | -225.36% | -309.70% | -419.08% | -381.32% | -313.33% | -468.85% | -422.00% | 0.00% |
| EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.06 | -0.07 | -0.07 | -0.08 | -0.06 | -0.04 | -0.05 | -0.07 | -0.09 | -0.09 | -0.15 | -0.13 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.06 | -0.07 | -0.07 | -0.08 | -0.06 | -0.04 | -0.05 | -0.07 | -0.09 | -0.09 | -0.15 | -0.13 | 0.00 |
| Weighted Avg Shares Out | 2.02B | 1.80B | 1.68B | 1.20B | 595.17M | 397.43M | 377.04M | 374.70M | 319.88M | 268.29M | 195.61M | 181.23M | 172.57M | 157.70M | 122.56M | 96.45M | 72.42M | 85.52M |
| Weighted Avg Shares Out (Dil) | 2.02B | 1.80B | 1.68B | 1.20B | 595.17M | 397.43M | 377.04M | 374.70M | 319.88M | 268.29M | 195.61M | 181.23M | 172.57M | 157.70M | 122.56M | 96.45M | 72.42M | 85.52M |
Source: https://incomestatements.info
Category: Stock Reports